Bayer fined $16.2M in price-fixing probe

Bayer was fined $16.2 million for fixing the prices of aspirin and other over-the-counter meds in Germany; the government alleged that a local Bayer subsidiary made illegal rebate deals with more than 21,000 pharmacies. Bayer denied the allegations, saying it agreed to the fine to avoid a long legal fight. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.